A notable research effort, known as the STEP (Semaglutide GLP-1 Treatment Effect in People with Obesity) trial, revealed that participants taking Semaglutide GLP-1 achieved an average weight reduction of around 15% of their starting body weight within 68 weeks, unlike those taking a placebo
More recently, she's been supporting select clients using GLP-1 medications when appropriate
Ill go into each of these treatments in more detail in future articles and videos, but heres a quick summary
Why it matters: A photo can start a useful conversation, but it cannot diagnose medication use
The habits, cues, or emotional patterns that felt easier to manage on medication may show up again once that buffer is gone
Weight Loss Through Telehealth Genesis Lifestyle Medicine provides medically supervised weight-loss plans that may include prescription options when clinically appropriate